These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 23044640

  • 21. Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.
    Clay E, Falissard B, Moore N, Toumi M.
    Eur J Clin Pharmacol; 2013 Apr; 69(4):1-10. PubMed ID: 23114457
    [Abstract] [Full Text] [Related]

  • 22. The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.
    Luthringer R, Muzet M, Zisapel N, Staner L.
    Int Clin Psychopharmacol; 2009 Sep; 24(5):239-49. PubMed ID: 19584739
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 24. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1918254. PubMed ID: 31880796
    [Abstract] [Full Text] [Related]

  • 25. Temazepam or Melatonin Versus Placebo for the Treatment of Insomnia in Advanced Cancer: A Three-Arm, Double-Blind, Phase III, Multicenter, Randomized Clinical Trial.
    Mendis R, Wong A, Frenkel S, Southcott AM, Selman CJ, Martin J, Grobler A, Currow D, Agar M, Le B, Philip J.
    J Palliat Med; 2024 Oct 02; 27(10):1368-1373. PubMed ID: 39304187
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.
    Sleep; 2009 Mar 02; 32(3):351-60. PubMed ID: 19294955
    [Abstract] [Full Text] [Related]

  • 27. Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS).
    Vecchierini MF, Kilic-Huck U, Quera-Salva MA, Members of the MEL consensus group of the SFRMS.
    Rev Neurol (Paris); 2021 Mar 02; 177(3):245-259. PubMed ID: 32921425
    [Abstract] [Full Text] [Related]

  • 28. [Melatonin--a natural hypnotic?].
    Saletu B.
    Wien Klin Wochenschr; 1997 Oct 03; 109(18):714-21. PubMed ID: 9441514
    [Abstract] [Full Text] [Related]

  • 29. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
    Serfaty MA, Osborne D, Buszewicz MJ, Blizard R, Raven PW.
    Int Clin Psychopharmacol; 2010 May 03; 25(3):132-42. PubMed ID: 20195158
    [Abstract] [Full Text] [Related]

  • 30. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M.
    Sleep; 2013 Feb 01; 36(2):189-96. PubMed ID: 23372266
    [Abstract] [Full Text] [Related]

  • 31. Improvement of sleep quality in elderly people by controlled-release melatonin.
    Garfinkel D, Laudon M, Nof D, Zisapel N.
    Lancet; 1995 Aug 26; 346(8974):541-4. PubMed ID: 7658780
    [Abstract] [Full Text] [Related]

  • 32. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study.
    Suresh Kumar PN, Andrade C, Bhakta SG, Singh NM.
    J Clin Psychiatry; 2007 Feb 26; 68(2):237-41. PubMed ID: 17335321
    [Abstract] [Full Text] [Related]

  • 33. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R, Rüther E, Farr I, Emilien G, Salinas E.
    J Clin Psychiatry; 1999 Aug 26; 60(8):536-44. PubMed ID: 10485636
    [Abstract] [Full Text] [Related]

  • 34. Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.
    Lähteenmäki R, Puustinen J, Vahlberg T, Lyles A, Neuvonen PJ, Partinen M, Räihä I, Kivelä SL.
    Br J Clin Pharmacol; 2014 Jun 26; 77(6):975-85. PubMed ID: 24286360
    [Abstract] [Full Text] [Related]

  • 35. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
    Hughes RJ, Sack RL, Lewy AJ.
    Sleep; 1998 Jun 26; 21(1):52-68. PubMed ID: 9485533
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 26; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 37. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.
    Tuft C, Matar E, Menczel Schrire Z, Grunstein RR, Yee BJ, Hoyos CM.
    Clin Interv Aging; 2023 Jan 26; 18():49-59. PubMed ID: 36660543
    [Abstract] [Full Text] [Related]

  • 38. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
    Braam W, Didden R, Smits M, Curfs L.
    J Intellect Disabil Res; 2008 Mar 26; 52(Pt 3):256-64. PubMed ID: 18261024
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
    Xu H, Zhang C, Qian Y, Zou J, Li X, Liu Y, Zhu H, Meng L, Liu S, Zhang W, Yi H, Guan J, Chen Z, Yin S.
    Sleep Med; 2020 Dec 26; 76():113-119. PubMed ID: 33157425
    [Abstract] [Full Text] [Related]

  • 40. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 26; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.